Drugs / VST-1001
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02294565 | Jun 2014 → Jan 2016 | female breast carcinoma | Vestan, Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VST-1001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02294565 ↗ |
| Modality | Diagnostic / imaging agent | “VST-1001 is used with medical devices (blue-light LED illuminator and blue-light filtering eyewear) for lymphatic mapping and localization of lymph nodes during a SLNB procedure.” NCT02294565 ↗ |
| Route | Other | “Single-dose injection (peritumoral, periareolar, and/or intradermal) of VST-1001 administered pre-SLNB procedure” NCT02294565 ↗ |